Literature DB >> 13773737

Treatment of chronic pyelonephritis. III. Comparison of several drugs combined and one member of the combination, colistin.

W R MCCABE, G G JACKSON.   

Abstract

Entities:  

Keywords:  PYELONEPHRITIS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13773737

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  5 in total

1.  In vitro activity of a combination of colimycin and tetracycline against Pseudomonas aeruginosa and Escherichia coli.

Authors:  R P MOUTON
Journal:  Antonie Van Leeuwenhoek       Date:  1961       Impact factor: 2.271

2.  Cross-infection in a surgical unit.

Authors:  P A Pompa; A D Caldwell
Journal:  Br Med J       Date:  1967-12-09

3.  Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate.

Authors:  Tianming Ren; Runzhi Li; Liqiang Zhao; J Paul Fawcett; Dong Sun; Jingkai Gu
Journal:  Acta Pharm Sin B       Date:  2022-01-25       Impact factor: 14.903

4.  TREATMENT OF INFECTIONS WITH COLISTIMETHATE SODIUM (COLY-MYCIN).

Authors:  K C RODGER; M NIXON; H O TONNING
Journal:  Can Med Assoc J       Date:  1965-07-24       Impact factor: 8.262

5.  High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.

Authors:  Rafael San-Juan; Esther Viedma; Fernando Chaves; Antonio Lalueza; Jesús Fortún; Elena Loza; Miquel Pujol; Carmen Ardanuy; Isabel Morales; Marina de Cueto; Elena Resino-Foz; Alejandra Morales-Cartagena; Alicia Rico; María P Romero; María Ángeles Orellana; Francisco López-Medrano; Mario Fernández-Ruiz; José María Aguado
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.